Current drug use as risk factor for erectile dysfunction: Results from an Italian epidemiological study

International Journal of Impotence Research

Volumn 15, Issue 3, 2003, Pages 221-224

  Ricci, E ^a   Parazzini, F ^a   Mirone, V ^c   Imbimbo, C ^c   Palmieri, A ^c   Bortolotti, A ^a   Di Cintio, E ^a   Landoni, M ^b   Lavezzari, M ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b PFIZER INC   (United States)

^c NONE

Author keywords

Drug adverse effect; Erectile dysfunction; Risk factors

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPOCHOLESTEROLEMIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONFIDENTIALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ERECTILE DYSFUNCTION; GENERAL PRACTITIONER; HUMAN; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL FUNCTION;

EID: 0041670854     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901008     Document Type: Article

References (17)

1. NIH Consensus Panel on Impotence. Impotence. JAMA 1993; 270: 83-90.
2. Parazzini F et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43-49.
3. Feldman HA et al. Impotence and its medical and psychosocial correlates: results from the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
4. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323-334.
5. Araujo AB et al. Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2000; 152: 533-541.
6. Derby CA et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302-306.
7. Miller NS, Gold MS. The human sexual response to alcohol and drugs. J Substance Abuse Treatment 1988; 5: 171-177.
8. Lue TF. Drug therapy: erectile dysfunction. N Engl J Med 2000; 342: 1802-1813.
9. Buffum J. Pharmacosexuology update: prescription drugs and sexual function. J Psychoactive Drugs 1986; 18: 97-106.
10. Grimm RH et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension 1997; 29: 8-14.
11. Nemeroff CB et al. Double-blind, placebo-controlled conparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158: 906-912.
12. Mirone V et al. Cigarette smoking as risk factor for erectile dysfunction: results from an italian epidemiological study. Eur Urol 2002; 42: 1-4.
13. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209-212.
14. Greenblatt DJ, Koch-Weser J. Gynecomastia and impotence: complications of spironolactone therapy. JAMA 1973; 223: 82.
15. Wolfe MM. Impotence on cimetidine treatment. N Engl J Med 1979; 300: 94-96.
16. Collen MJ et al. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med 1984; 100: 52-58.
17. Jensen RT et al. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 1984; 77: 90-105.